Three rare pathogenic mtDNA substitutions in LHON patients with low heteroplasmy

• DOI: 10.1016/j.mito.2019.10.002
• Publication Date: 2019-10-26T05:44:18Z
• Authors: Tatiana D. Krylova; Natalia L. Sheremet; Vyacheslav Yu. Ta...; Konstantin G. Lya...; Yulia S. Itkis; Polina G. Tsygankova; Natalia A. Andreeva; Maria S. Shmelkova; Tatiana A. Nevini...; Vitaly V. Kadyshev; Ekaterina Yu. Zak...
• Keywords: Adult; Membrane Potential, Mitochondrial; Paraquat; 0301 basic medicine; Herbicides; Optic Atrophy, Hereditary, Leber; Fibroblasts; Heteroplasmy; DNA, Mitochondrial; 3. Good health; Young Adult; 03 medical and health sciences; Humans; Point Mutation; Female; Cells, Cultured

In this article we present clinical, molecular and biochemical investigations of three patients with LHON caused by rare point substitutions in mtDNA. One patient harbours the known mtDNA mutation (m.13513 G>A), the others have new variants (m.13379 A>G in MT-ND5 gene and m.14597 A>G in MT-ND6 gene, which has never been previously associated with LHON). NGS analysis of a whole mtDNA derived from patient's blood revealed a low mutation load (24%, 47%, 23% respectively). Our data, including family segregation analysis, measurement of reactive oxygen species (ROS) production and cytotoxic effect of paraquat and high-resolution respirometry, showed that nucleotide variant m.14597 A>G can be classified as pathogenic mutation.